Episode 539 - Uromigos Live 2026 – Are Doublets the New Standard of Care Throughout the RCC Continuum?
From The Uromigos · · 41 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Doublet therapy has produced positive results in the adjuvant and refractory RCC settings. Are they the standard of care and what is the role of monotherapy for individual patients?